Analysis of decision-making for hemodialysis access choices
Clinical Decision Tree Analysis of Hemodialysis Arteriovenous Access Choices and Creations - a Multiple-center Retrospective Cohort Study
This study looks at how patients and doctors decide on the best type of access for hemodialysis to help improve choices and outcomes for people needing kidney treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06364449 on ClinicalTrials.gov |
What this trial studies
This study utilizes a decision tree analysis model to explore the decision-making process regarding arteriovenous access for hemodialysis in a cohort of patients across multiple centers. It aims to understand how physicians and patients make choices about AV access types, considering factors like patient life expectancy and the limitations of different access methods. By analyzing these decisions, the study seeks to improve the decision-making process in clinical kidney practice and minimize potential harm to patients. The research focuses on adult patients who are in the pre-kidney replacement therapy stage or those who urgently require hemodialysis.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 80 who are referred for primary hemodialysis AV access creation.
Not a fit: Patients who have already undergone secondary AV access surgeries will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the decision-making process for hemodialysis access, leading to better patient outcomes.
How similar studies have performed: Other studies utilizing decision tree analysis in medical decision-making have shown promise, indicating that this approach could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- adult patients between the ages of 18 and 80 who were referred for primary hemodialysis (HD) AV access creation. We included those in the pre-kidney replacement therapy (pre-KRT) stage and those who in the early end-stage kidney disease (ESKD) urgently started HD without sufficient time to plan for AV access Exclusion Criteria: \- patients who underwent a secondary AV access surgery, like a transposed radiobasilic AVF or a revision of AVG.
Where this trial is running
Taipei
- National Taiwan University Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Principal investigator: Chih-Yang Chan, phd — National Taiwan University Hospital
- Study coordinator: Chih-Yang Chan, phd
- Email: chanchihyang@gmail.com
- Phone: +88672651147
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.